Showing results (41-50 of 194) with videos related to
Sort By:
Pageof 20
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Altered selection of CD4+ T cells by class II MHC bound with dominant and low abundance self-peptidesA Gaszewska-Mastalarz, P Muranski, B Chmielowski, et al.Optics Express|October 20, 2023
Distributed and polarimetric pressure sensitivity in spun highly birefringent optical fibersMarta Bernaś, Przemysław Chmielowski, Małgorzata Garbacka, et al.Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|April 1, 1997
[Comparison of clinical and histopathologic diagnosis for early stages of advanced nonseminomatous germ cell testicular tumors]M Sosnowski, A Płuzańska, M Chmielowski, et al.Current Oncology (Toronto, Ont.)|December 13, 2021
Management of Clitoral Melanoma Presenting as an Exophytic Clitoral Mass: A Case Report and Review of the LiteratureAlec Szlachta-McGinn, Bartosz Chmielowski, Yuna Kang, et al.Cellular & Molecular Biology Letters|July 19, 2006
The specific T-cell response to antigenic peptides is influenced by bystander peptidesIzabela Nowak, Elzbieta Pajtasz-Piasecka, Bartosz Chmielowski, et al.Scientific Reports|April 4, 2025
Isolation and assessment of antibiotic resistance of Staphylococcus aureus in the air of an underground hard coal minesIwona Beata Paśmionka, Piotr Cheluszka, Janina Gospodarek, et al.Acta Haematologica Polonica|January 1, 1993
[Comparison of computed tomography results and pathological findings after laparotomy with splenectomy in Hodgkin's disease]A Płuzańska, E Chmielowska, M Chmielowski, et al.Journal of Managed Care & Specialty Pharmacy|January 27, 2017
Cost-Effectiveness of Pembrolizumab Versus Ipilimumab in Ipilimumab-Naïve Patients with Advanced Melanoma in the United StatesJingshu Wang, Bartosz Chmielowski, James Pellissier, et al.Neurologia I Neurochirurgia Polska|May 1, 1995
[Cerebral blood flow changes after mild head trauma imaging with SPECT HMPAO. Preliminary report]J Furtak, K Chmielowski, J K Podgórski, et al.Journal of Managed Care & Specialty Pharmacy|April 5, 2019
Health Care Resource Utilization and Costs in First-Line Treatments for Patients with Metastatic Melanoma in the United StatesAndrew J Klink, Bartosz Chmielowski, Bruce Feinberg, et al.Pageof 20